Clinical Trial Results: A Research Study to See How Switching From a Daily Basal Insulin to a New Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine in Adults With Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial comparing switching from daily basal insulin (glargine) to weekly insulin icodec in adults with type 2 diabetes, assessing impact on blood sugar c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin Glargine (insulin glargine)
• Insulin Icodec (insulin icodec)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2026-07-02